en · de · es · fr · pt
compound-index.peptides1126.com › Info › Melanotan-2 Identity And Receptor Pharmacology — Worked Examples

Melanotan-2 Identity And Receptor Pharmacology — Worked Examples

By Editorial Desk · published 2025-11-05 · last reviewed 2025-11-20 · Info

A practical reference on alpha-MSH analogue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2025-11-20 and is reviewed periodically as new material appears.

Melanotan-2 Identity and Receptor Pharmacology

Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.

Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.

Background and Receptor Mechanism

Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.

Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.

Melanotan-2 at a glance

PropertyValueNotes
Common synonymsMelanotan II; MT-II; N-acetyl-norleucyl-cyclo[Asp-His-D-Phe-Arg-Trp-Lys] amideNaming follows peptide convention; the numeral distinguishes it from melanotan-1
Molecular formulaC50H69N15O9Includes the lactam bridge; no counter-ion assumed
Monoisotopic mass1023.53 DaFree base; salts and counter-ions shift the observed value
AppearanceWhite to off-white lyophilised powderBatch-to-batch colour variation is not itself proof of impurity
Typical analytical methodRP-HPLC purity determination with ESI-MS identity confirmationRetention time alone does not establish sequence identity

Chemistry and Receptor Pharmacology

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Related pages on this site

Peptide Identity and Structural Background

Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.

Further detail

== Early life and education == Arthur 'Blaine' Bowman was born in 1946 in Ogden, Utah, US. Around age 10, his family moved to Southern California, where he grew up. Bowman attended Brigham Young University in Provo, Utah in the physics program. As an undergraduate, he worked in the summer as an engineer at McDonnell Douglas, testing modules for the Apollo rocket. Bowman received his B.S. in physics in 1970. Next, Bowman worked as a product engineer at Motorola's Semiconductor Products Division in Phoenix, Arizona, where he became interested in business. He attended Stanford University's school of business from 1971 to 1973, receiving his M.B.A. in 1973. He then joined McKinsey & Company as a management consultant.

By the 19th century, it had become increasingly recognised that migraine was not always confined to one side of the head. Consequently, the historical term hemicrania came to encompass conditions now classified as migraine, although it may also have included other headache disorders. In 1887, the French librarian Louis Hyacinthe Thomas distinguished two forms of migraine, "migraine ophthalmique" and "migraine vulgaire", corresponding broadly to what are now known as migraine with aura and migraine without aura. Although numerous treatments for migraine had been attempted, it was not until 1868 that ergot was introduced as a treatment. Canadian physician William Osler, included a chapter on migraine in his 1892 The Principles and Practice of Medicine, the gold standard medical text of the day. He described the treatments commonly used by physicians, including ergot, cannabis, bromides, caffeine, and pain-relieving medicines including antipyrin and phenacetin.

== Disorders == The body's hemostasis system requires careful regulation in order to work properly. If the blood does not clot sufficiently, it may be due to bleeding disorders such as hemophilia or immune thrombocytopenia; this requires careful investigation. Over-active clotting can also cause problems; thrombosis, where blood clots form abnormally, can potentially cause embolisms, where blood clots break off and subsequently become lodged in a vein or artery. Hemostasis disorders can develop for many different reasons. They may be congenital, due to a deficiency or defect in an individual's platelets or clotting factors. A number of disorders can be acquired as well, such as in HELLP syndrome, which is due to pregnancy, or Hemolytic-uremic syndrome (HUS), which is due to E. coli toxins.

After several months of competing as a mid-card talent and doing little of note, Austin's rise in popularity began at the 1996 King of the Ring, where he won the tournament by defeating Jake "The Snake" Roberts. The win would prove to be an unexpected stroke of luck as Hunter Hearst Helmsley was originally scheduled to win the tournament, but he was legitimately punished for taking part in the Curtain Call incident before the tournament. At the time, Roberts was portraying a born-again Christian, which inspired Austin to ad-lib a famous promo during his post-win coronation, kayfabe mocking Roberts' religious faith and proclaiming the now-iconic catchphrase "Austin 3:16" as derision of the Bible verse John 3:16. At the conclusion of this same promo, he further ad-libbed the line, "And that's the bottom line, cuz Stone Cold said so." This was the first usage of the "bottom line" and "Austin 3:16", which eventually would become one of the most iconic catchphrases in wrestling history, and one of the best-selling T-shirts in WWE merchandise history. Years later, Austin would say of this moment, "It's like I got two at-bats and hit two grand slams."His raw speech, which included the word "ass" and the unintentional sacrilegious reference, sparked the gradual cultivation of his persona as a foul-mouthed, sadistic and antihero character.

===== Epikeratophakia ===== Rarely, a nonpenetrating keratoplasty known as an epikeratophakia (or epikeratoplasty) may be performed in cases of keratoconus. The corneal epithelium is removed and a lenticule of donor cornea is grafted on top of it. The procedure requires a greater level of skill on the part of the surgeon, and is less frequently performed than a penetrating keratoplasty, as the outcome is generally less favorable. However, it may be seen as an option in a number of cases, particularly for young people.

Sources: en.wikipedia.org

Background from the literature

=== Systemic therapies === Because many cases of AN are associated with metabolic dysfunction, improvement in weight or insulin sensitivity may coincide with changes in the skin. Metformin, which is widely used for insulin resistance and type 2 diabetes, has been reported in case series and observational studies to coincide with improvement in AN; however, high-quality randomized trials with AN as a primary outcome are not available. Glucagon-like peptide-1 (GLP-1) receptor agonists, used for obesity and diabetes, have also been associated with improvement in some individuals with AN in observational reports, likely secondary to changes in metabolic status. These medications are not used specifically to treat AN, and evidence remains indirect.

ICT appears to be vanishing as a result of greater genetic diversity within the affected populations in conjunction with educational programs to ensure that tinned cooking utensils are used instead of copper pots and pans being directly exposed to cooked foods. The preponderance of cases of early childhood cirrhosis identified in Germany over a period of 10 years were not associated with either external sources of copper or with elevated hepatic metal concentrations Only occasional spontaneous cases of ICT arise today.

The Houthis stepped up their pressure on Hadi's weakened government, seizing the presidential palace and strategic military installations in Sanaa and shelling the president's private residence on 20 January. The following day, they took control of Hadi's home, stationing armed guards outside to keep him under virtual house arrest. Hadi, Prime Minister Khaled Bahah, and the cabinet resigned the following day, saying they could not continue to work under the conditions the Houthis had imposed. The rebel group welcomed Hadi's resignation, but continued to keep him under house arrest. The news prompted four southern governorates to announce they would disregard all orders from Sanaa. The House of Representatives was to meet on 25 January to discuss whether to accept or reject Hadi's resignation under the Yemeni constitution, but the session was cancelled after the Houthis took control of the parliament building. The United Nations stepped in to attempt a negotiated resolution to what many in Yemen regarded as a Houthi coup. UN negotiations were fruitless, and a Houthi ultimatum to Yemen's political factions to find a solution was not met. On 6 February, the Houthis declared themselves in total control of the Yemeni government, dissolving parliament and installing a Revolutionary Committee led by Mohammed Ali al-Houthi to lead the state in an interim capacity. The announcement sparked protests in Sanaa and other cities, especially in the south.

Hurley showed tremendous form throughout the TAC Cup, showing his all-round quality for the Northern Knights. He was named All-Australian in 2007 and backed it up with another selection after the 2008 AFL Under 18 Championships and was also selected in the TAC Cup Team of the Year in both seasons. He made his debut against the Port Adelaide Power in round 1, 2009, and was nominated twice as the AFL Rising Star nominee, in round 20 of that season, and round 18 the following year, both times against St Kilda. After his match-winning four goal performance against Hawthorn in round 22, 2009, Leigh Matthews said, "Very few young talls have the physical maturity to match it with their older and stronger opponents, which is why the brilliant early form of young Bomber Michael Hurley is quite amazing." Ahead of the 2010 season, Hurley inherited the famous number 18 guernsey from retired club great Matthew Lloyd. The following four seasons saw Hurley's form fluctuate due to injury and the constant shuffling of his position in the team between both ends of the ground. He averaged 22 goals per season, and spent just as much time playing in the back line on some of the opposition's best key forwards, where his precise kicking and attacking flair out of the back half were noticeable on numerous occasions. The 2014 season brought with it a permanent role for Hurley as a key defender, the position for which he was initially drafted. This newfound positional consistency allowed him to really begin to shine as a footballer.

Sources: en.wikipedia.org

Further detail

== History == DART resulted from conversations between Laramee and Cody about the development of an atmospheric pressure ion source to replace the radioactive sources in handheld chemical weapons detectors. DART was developed in late 2002 to early 2003 by Cody and Laramee as a new atmospheric pressure ionization process, and a US patent application was filed in April 2003. Although the development of DART actually predated the desorption electrospray ionization (DESI) ion source, the initial DART publication did not appear until shortly after the DESI publication, and both ion sources were publicly introduced in back-to-back presentations by R. G. Cooks and R. B. Cody at the January 2005 ASMS Sanibel Conference. DESI and DART are considered as pioneer techniques in the field of ambient ionization, since they operate in the open laboratory environment and do not require sample pretreatment. In contrast to the liquid spray used by DESI, the ionizing gas from the DART ion source contains a dry stream containing excited state species.

== History == In 2010, Wang Yun'an founded Good me after graduating from Zhejiang Sci-Tech University. The company opened its first store in Wang's hometown of Daxi in Taizhou, Zhejiang, which had a population under 200,000. In its early stages, the business reportedly experienced low sales volumes. Over time, Good me adopted a franchise-based expansion model, targeting lower-tier cities. The company emphasized cost-effective store designs and consistent branding elements such as bright lighting. Good me's expansion was supported by the development of a cold chain logistics system, which enabled frequent delivery of fresh ingredients to franchise location. According to China Daily, industry sources have cited this logistics capability as a factor contributing to its competitive position in the market By the end of 2023, Good me had almost 10,000 stores and was second largest among its peers (behind Mixue Ice Cream & Tea) in terms of total sales and number of stores. In September 2024, a video posted on Chinese social media depicted staff with their heads lowered and their hands bound with mock handcuffs made from cardboard cup holders while wearing placards that listed their workplace 'offenses.' The caption read: "This is a warning. Next time…there will be no next time." The post drew criticism online; the company removed the clip, and on September 18, 2024, issued an apology. A staff quoted in media coverage said the video was intended as a joke and did not reflect actual workplace practice.

=== Portugal === The Portuguese Armed Forces developed and fields the RIC (Portuguese: Ração Individual de Combate). Packed in a camouflage cardboard box measuring 265 mm × 160 mm × 90 mm (10.4 in × 6.3 in × 3.5 in) and weighing 2 kg (4.4 lb), the ration provides 3 meals per day. Maximum use is made of off-the-shelf commercial items, including canned main menu items (still with their original labels). A typical RIC (menu 4) contains: two 415 g "poptop" cans (beef with vegetables and chili con carne), a flat 115 g can of sardines, round 65 g can of liver paste, sweet bread, crackers, packaged bread, 2 pouches of fruit jam, pouch of quince cream, hot chocolate or instant coffee, isotonic drink mix, instant milk powder, chewing gum, boiled sweets, sugar, salt, water purification tablets, matches, 6 fuel tablets, a folding stove, plastic cutlery, a pack of tissues, a plastic bag, and an instruction/menu sheet.

Positive psychology is the branch of psychology dedicated to the study of well-being and related phenomena, like happiness and flourishing. It examines the factors and conditions of optimal human functioning. This inquiry focuses both on individual factors, like the experience of pleasure and pain and the role of character traits, and on societal factors, such as the way social institutions influence human well-being. At the emotional level, positive psychologists examine the different types of positive emotions, such as joy, amusement, and love. They seek to understand the conditions under which positive emotions arise, how they contribute to overall well-being, and how they differ from negative emotions. At the cognitive level, positive psychology studies how intelligence, wisdom, and creativity improve quality of life. It further explores the relation between cognitive and affective processes, for example, how cognitive interpretations evoke emotions and how emotions prompt thought processes. Another central subfield concerns the role of personality, in particular, how individuals differ regarding personality traits and how these traits impact well-being. The VIA model, an influential framework in positive psychology, analyzes personality based on six main virtues: wisdom, courage, humanity, justice, temperance, and transcendence. A closely related topic focuses on the role of the self, which encompasses the way a person conceptualizes and imagines themselves.

Pharmacological stimulation of arteriogenesis, important for the treatment of arterial occlusive diseases, seems feasible with NO donors." Kolibash's 1982 study of the effect of collaterals on rest and stress myocardial perfusion, left ventricular function, and myocardial infarction prevention was most influential in turning the tide of professional opinion toward acknowledging the impact of these vessels on the jeopardized heart. In 91 patients examined by angiography, 90% of which had exertional angina, Kolibash discovered 110 occluded LAD and RCA vessels, 101 of which showed evidence of collateral vessels in their proximal areas. Kolibash divided these 101 proximal areas into two groups: those with normal perfusion at rest (43) and those with abnormal perfusion at rest (58). Wall motion abnormalities were significantly less evident in areas with normal rest perfusion—only 35% of these areas showed decreased segment shortening. By comparison, 72% of areas with abnormal rest perfusion showed decreased segment shortening. Infarctions also occurred less often in the normals than in the abnormals (12% vs. 62%). Examining four variables—rest perfusion, stress perfusion, wall motion abnormalities, and EKG evidence of MI, Kolibash found that 86% of the variables were normal in the normal perfusion group and 81% of the variables were abnormal in the abnormal perfusion group.

Sources: en.wikipedia.org

Frequently asked questions

What is melanotan-2 chemically?

It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.

How does it differ from the natural hormone?

The natural hormone is a linear tridecapeptide that is rapidly degraded in circulation. Melanotan-2 is shortened, cyclised, N-terminally acetylated, and carries a D-amino acid substitution, all of which slow enzymatic breakdown.

Does it hold any regulatory approval?

No national medicines regulator has approved melanotan-2 for therapeutic or cosmetic use. In several jurisdictions it is treated as an unapproved prescription medicine, and its legal classification differs from country to country.

Is melanotan II an approved medication?

No regulator in a major market has approved it for human use. It appears in research settings and in products marketed outside pharmacy channels. Legal status for personal possession varies by country.

Network